(MENAFN- The Express Wire) Posted on Oct 19 2021 4:46 AM
"Active Wound Care Market by Top key Players are Integra Life Sciences Corporation, Organogenesis, Inc., and MiMedex, Tissue Regenix, Cytori Therapeutics Inc., Coloplast Corporation, MTF Biologics, Smith & Nephew, Acell Inc, Osiris Therapeutics, Inc., Baxter, Wright Medical Group N.V., and Solsys Medical."
Rising prevalence of diabetes will help the global“Active Wound Care Market 2021” gain momentum, predicts Fortune Business Insights, in their recent study. The study is titled“Active Wound Care Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” The market, as per the study is prognosticated to exhibit a CAGR of 5.3% and be worth US$ 2039.9 Mn from US$ 1361.7 Mn within the forecast period of 2018 to 2025.
The report covers:
- Global Active Wound Care Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
“Get Sample PDF of report, please connect with our sales team below.“
Name: Mr. Ashwin Arora
Email: sales [@] fortunebusinessinsights [.] com
Phone: US +1424 253 0390 / UK +44 2071 939123
Integra Life Sciences Corporation, Organogenesis, Inc., and MiMedex to Lead Market
Geographically, the global active wound care market is witnessing immense growth opportunities in North America. This is because of the increasing prevalence of diabetic population and wound cases in the region, resulting from road accidents. The presence of sophisticated healthcare services in the region is also aiding the growth of the market. On the other side, wound dressing market in Asia Pacific is anticipated to show significant rise in future owing to the considerable growth of the healthcare sector in the emerging nations of India, and China. Rise in population and increasing healthcare awareness in these nations will drive the market in Asia Pacific, making it the fastest growing region during the forecast period.
Among leading players operating in the market, Integra Life Sciences Corporation, Organogenesis, Inc., and MiMedex, are expected to be on the top. Other players in the market are Tissue Regenix, Cytori Therapeutics Inc., Coloplast Corporation, MTF Biologics, Smith & Nephew, Acell Inc., Osiris Therapeutics, Inc., Osiris Therapeutics, Inc., Baxter, Wright Medical Group N.V., and Solsys Medical.
Increasing Demand for Emergency Medical Aid Services to Propel Market
With the rise in geriatric population and their vulnerability to contract various diseases, especially chronic diseases, the demand for active wound care is expected to rise. Besides this, the rise in the number of road accidents and increasing demand for emergency medical aid will also help the market to gain momentum in the coming years
Furthermore, the market is expected to benefit from governments initiatives and rising investment towards the research and development (R & D) of novel healthcare solutions. Technological advancements aimed at transforming the prevailing active wound care trends will also help the market gain momentum.
“Have Any Query? Ask Our Expert:“
Name: Mr. Ashwin Arora
Email: sales [@] fortunebusinessinsights [.] com
Phone: US +1424 253 0390 / UK +44 2071 939123
Detailed Table of Content:
Introduction 1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
Executive Summary Market Dynamics 3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
Key Insights 4.1 Prevalence of Key Disease Indications (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers Etc.) for Key Countries/Region
4.2 Recent Industry Developments such as Partnerships, Mergers & Acquisitions
4.3 New Product Launches
4.4 Regulatory Framework by Key Countries
4.5 Reimbursement Scenario, Key Countries
4.6 Economic Cost Burden For The Treatment Of Chronic Wounds By Key Countries/ Region
Global Active Wound Care Market Analysis, Insights and Forecast, 2014-2025 5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product Type
5.2.1 Biological Skin Equivalents
5.2.1.1 Allografts
5.2.1.2 Xenografts
5.2.1.3 Cell-based Therapies
5.2.2 Growth Factors
5.2.2.1 Epidermal Growth Factors
5.2.2.2 Platelet-derived Growth Factors
5.2.2.3 Others
5.2.3 Biological Dressings
5.2.3.1 Collagen Dressings
5.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.)
5.2.4 Others
5.3. Market Analysis, Insights and Forecast – By Indication
5.3.1 Diabetic Foot Ulcers
5.3.2 Pressure Ulcers
5.3.3 Lower Limb Ulcers
5.3.4 Others
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1 Hospitals
5.4.2 Clinics
5.4.3 Home Care Settings
5.4.4 Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1 North America
5.5.2 Europe
5.5.3 Asia Pacific
5.5.4 Latin America
5.5.5 Middle East & Africa
MENAFN19102021004576010663ID1102991953
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.